BioNTech reports strong H1 with $9.7-bn revenue, expects demand to grow

The German pharmaceutical company said Monday that revenue hit about 9.57 billion euros ($ 9.76 bn) in the first six months of 2022, up from nearly 7.36 billion euros in the same period a year earlier